LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 220 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $214,000 | -27.0% | 1,900 | 0.0% | 0.07% | -22.2% |
| Q4 2021 | $293,000 | +10.6% | 1,900 | 0.0% | 0.09% | +3.4% |
| Q3 2021 | $265,000 | +6.4% | 1,900 | 0.0% | 0.09% | +7.4% |
| Q2 2021 | $249,000 | -14.1% | 1,900 | 0.0% | 0.08% | -19.8% |
| Q1 2021 | $290,000 | +36.2% | 1,900 | 0.0% | 0.10% | +4.1% |
| Q2 2020 | $213,000 | -25.0% | 1,900 | -51.3% | 0.10% | -38.6% |
| Q1 2020 | $284,000 | -30.2% | 3,900 | 0.0% | 0.16% | -6.0% |
| Q4 2019 | $407,000 | +4.9% | 3,900 | 0.0% | 0.17% | -5.1% |
| Q3 2019 | $388,000 | -32.0% | 3,900 | -22.0% | 0.18% | -29.5% |
| Q2 2019 | $571,000 | -9.2% | 5,000 | 0.0% | 0.25% | -10.0% |
| Q1 2019 | $629,000 | – | 5,000 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |